Kurt H Kruger's Net Worth

-$201 Thousand

Estimate Recalculated Feb 7, 2024 03:58PM EST

Who is Kurt H Kruger?

Kurt H Kruger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EMMAUS LIFE SCIENCES, INC., Cyberkinetics Neurotechnology Systems, Inc., and Qualigen Therapeutics, Inc..

SEC CIK

Kurt H Kruger's CIK is 0001375881

Past Insider Trading and Trends

2020 was Kurt H Kruger's most active year for acquiring shares with 5 total transactions. Kurt H Kruger's most active month to acquire stocks was the month of July. 2006 saw Kurt H Kruger paying a total of $158,000.00 for 400,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EMMAUS LIFE SCIENCES, INC. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 16
Form 3
—
0
—
—
0
No matching records found

Cyberkinetics Neurotechnology Systems, Inc. No price found

CFO

Kurt H Kruger owns 258,297 units of Common Stock. In the year 2006 Kurt H Kruger acquired a total of 208,297 shares in Cyberkinetics Neurotechnology Systems, Inc. at a cost of $167,375.61.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+63.17%
100K
—
—
258.3K
Nov 9
Form 4
∞
8.3K
$1.13
$9,375.61
8.3K
Mar 2
Form 4
—
0
—
—
0
Feb 27
Form 4
+200.00%
100K
$1.58
$158,000.00
150K
Sep 18
Form 3
—
0
—
—
0
No matching records found

Qualigen Therapeutics, Inc. (QLGN) Snapshot price: $0.499899

Investor

Kurt H Kruger owns 18,000 units of Common Stock which is worth $8,998.18. From 2020 to 2022 Kurt H Kruger acquired a total of 18,000 shares in Qualigen Therapeutics, Inc. at a cost of $42,433.80.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 11
Form 4
+80.00%
8K
$1.23
$9,800.00
18K
Aug 19
Form 4
+66.67%
4K
$2.94
$11,740.00
10K
Dec 29
Form 4
∞
6K
$3.48
$20,893.80
6K
Nov 20 - Nov 23
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 22
Form 3
—
0
—
—
0
No matching records found